drugstudy_ grand cp
TRANSCRIPT
-
7/29/2019 Drugstudy_ Grand Cp
1/16
NAME OF PATIENT: DRUGSTUDY DIAGNOSIS:
Name of Drug DateOrdered
Classification
Recommended Dose& Frequency
Why given to patientin relation to the
mechanism of action
Contraindication SideEffects/Toxic
effects/Drug-druginteraction
Stability of theDrug
Nursing Consider
Generic (Brand)
Acetylcysteine
( Flumucil )
Dose/FrequencyPrescribed
60mg in glass
H2O OD
November19, 2012
Mucolytic
PO loading dose:
140mg/kg;
Maintenance dose:70mg/kg 4hr after the
loading dose andevery 4hr thereafter
for a total of 17doses.
Reduces the
viscosity of purulentand non purulent
pulmonarysecretions and
facilitates theirremoval by splitting
disulfide bonds.
Therapeutic action:
Mucolytic activity,splits links in the
mucoproteinscontained in
respiratory mucussecretions,
decreasing the
viscosity of themucus.
Contraindicated
withhypersensitivity
to acetylcisteine;use caution and
discontinueimmediately if
bronchospasmoccurs.
Most common:
bronchial/tracheal
irritation nausea &
vomiting rash stomatitis.
Closed bottles
of solutionremain stable
for 2 yearswhen stored at
20 degreeCelsius. Open
bottle shouldbe stored at 2-8
degree Celsiusand should be
used within96hr. once a
bottle has beenopened, record
the time anddate of opening
so that the drug
will not beused beyond
the 96hrperiod.
Use non-reactplastic glass ostainless steel
administration Note pulmona
findings, detewhen spasm o
Document conthat likely cau
congestion &wheezing.
Use as directenot exceed pre
dosage. report sputum
consistency,characteristic,
set fever.
report lack of response adve
effects, or woof symptoms.
-
7/29/2019 Drugstudy_ Grand Cp
2/16
NAME OF PATIENT: DRUGSTUDY DIAGNOSIS:
Name of Drug DateOrdered
Classification RecommendedDose &
Frequency
Why given to patientin relation to the
mechanism of action
Contraindication Side Effects/Toxiceffects/Drug-drug
interaction
Stability ofthe Drug
Nursing Consid
Generic (Brand)
Ipratropium
Bromide andAlbuterol
Sulfate(Combivent)
Dose/FrequencyPrescribed
1 neb TID
November19, 2012
Antiasthmatic
One 3ml vialgiven 4 times per
day vianebulization with
up to 2additional 3ml
doses daily, ifneeded.
Treatment of COPD(including
bronchospasm) inthose who are on
regular aerosolbronchodilator
therapy and whorequire a second
bronchodilator.
History ofhypersensitivity to
lecithin or relatedfood products such
as soy bean andpeanuts.
Most common:
bronchitis URTI headache pain dyspnea coughing nausea pharyngitis sinusitis
Store between15-30 degree
Celsius (59-86 degree
Fahrenheit)avoid
excessivehumidity.
discard canlabeled num
inhalations use as direc
not increasdoe/freque
administratspecifically
avoid eye creport any
disturbanceirritation.
-
7/29/2019 Drugstudy_ Grand Cp
3/16
NAME OF PATIENT: DRUGSTUDY DIAGNOSIS:
Name of Drug DateOrdered
Classification RecommendedDose & Frequency
Why given topatient in relation
to the mechanismof action
Contraindication Side Effects/Toxiceffects/Drug-drug
interaction
Stability ofthe Drug
Nursing Consi
Generic (Brand)
Potassium Chloride
(Kalium Durule)
Dose/FrequencyPrescribed
2 tab OD
November
15, 2012
Electrolyte
Highly
individualized.Oral
administration ispreferred because
the slowabsorption from
the GI tractprevents sudden
large increases inplasma potassium
levels. Dosage isusually expressed
as mEq/L ofpotassium.
The usual adult
daily requirement
of potassium is 40-80mg.
It is given to
client to treathypokalemia due
to digitalisintoxication,
diabetic acidosis,diarrhea and
vomiting, familialperiodic paralysis,
certain cases ofuremia, starvation
and debilitation,and corticosteroid
and diuretictherapy.
severe renalfunctionimpairment with
azotemia oroliguria,postopera
tively beforeurine flow has
beenreestablished.
Crush syndrome Addisons disease Hyperkalemia
from any cause
Anuria Heat cramps acute dehydration severe hemolytic
reaction
adynamia clients receiving
potassium -sparing diureticsor aldosteroneinhibiting drugs.
CNS:
dizziness mental
confusionCV:
arrhythmia weak irregular
pulse
hypotension
heart blockGI:
abdominaldistention
anorexia nausea &
vomitingNEUROMUSCULAR
weakness paresthesia
of
extremities
flaccidparalysis.
Store between
15-30 degreeCelsius (59-
86 degreeFahrenheit)
avoidexcessive
humidity
instruct cswallow coated ta
extendedcapsules
tablets andissolve
the mout salt subs
should nused
concomiwith pota
preparati if GI ups
occurs, pcan be ta
meals or
food withglass of w
give oral times dailHypokaleshould beslowly ov
period of to minimi
developmhyperkale
-
7/29/2019 Drugstudy_ Grand Cp
4/16
NAME OF PATIENT: DRUGSTUDY DIAGNOSIS:
Name of Drug Date
Ordered
Classification Recommended Dose
& Frequency
Why given to patient
in relation to themechanism of action
Contraindication Side
Effects/Toxiceffects/Drug-
drug interaction
Stability of
the Drug
Nursing Consider
Generic (Brand)
Fluconazole
( Diflucan)
Dose/Frequency
Prescribed
200mg 1cap OD
November
26, 2012
Antifungalagent
Adults:First day: 200mg
then, 100mg oncedaily for a minimum
of 14 days.
It is given to clientto treat
oropharyngeal andesophageal
candidiasis. serioussystemis candidal
infection (includingUTI, peritonitis, and
pneumonia).
Therapeutic action:
Binds to sterols inthe fungal cell
membrane, changingmembrane
permeability,fungicidal or
fungistaticdepending on
concentration and
organism.
Contraindicated with
hypersensitivity to
fluconazole, lactation.
usecautiously
with renal
or hepaticimpairment
Side effects aremore frequently
reported in HIVinfected clients
than in nonHIVclients.
GI:
nausea vomiting abdomina
l pain diarrhea
Miscellaneous:
headache skin rash hepatotox
icity
exfoliative skin
disorders.
Store between
15-30 degreeCelsius (59-
86 degreeFahrenheit)
avoidexcessive
humidity
Take a througnursing and d
Determine if cHIV infected
possible) becamay place clie
increased riskpossible side e
Due to a long once daily dos
(either IV or P
possible. Obtain baseline
function studiewho develop abliver function tshould be closemonitored for tdevelopment oserious liver to
Observeimmunocomprclients closely evidence of a r
lesions progresdrug should bediscontimued.
-
7/29/2019 Drugstudy_ Grand Cp
5/16
NAME OF PATIENT: DRUGSTUDY DIAGNOSIS:
Name of Drug Date
Ordered
Classification Recommended Dose
& Frequency
Why given to patient
in relation to themechanism of action
Contraindication Side
Effects/Toxiceffects/Drug-drug
interaction
Stability of
the Drug
Nursing Consider
Generic (Brand)
Azithromycin(Zithromax)
Dose/Frequency
Prescribed
500 mg/tab 1 tabOD
November
15, 2012
Macrolide
antibiotic
Adults:500 mg PO single
dose on first day,followed by 250 mg
PO daily on days 2-5for a total dose of
1.5g or 500 mg/dayPO for 3 days.
Treatment of lowerrespiratory
infections: acutebacterial
exacerbations ofCOPD.
Therapeutic action:
Bacteriostatic or
bactericidal insusceptible bacteria.
Contraindicatedwith
hypersensitivityto azithromycin,
erythromycin, orany macrolide
antibiotic.
CNS:
Dizziness, headache,
vertigo,
Somnolence, fatigue
GI:
Diarrhea, abdominal
pain,
Nausea,dyspepsia
Flatulence, vomiting,
mmelena
other:
superinfections,
angioedema,
rash, vaginitis.
DRUG-DRUG
INTERACTIO:
Decreased serum
levels and
effectiveness of
azithromycin with
aluminum and
magnesium-
containing antacids.
Possible increased
effects of
theophylline.
Possible increased
anticoagulant effectsof warfarin.
Storebetween 15-
30 degreeCelsius (59-
86 degreeFahrenheit)
avoidexcessive
humidity
Culture site ofinfection befo
therapy. Administer on
stomach 1hr b2-3hr after me
Food affects tabsorption of
drug. Take the full c
prescribed. Do
take with antaTablets and orsuspension ca
taken with or food.
You may expethese side effe
stomach cramdiscomfort, di
fatigue,headache;add
infections in t
mouth or vagi
-
7/29/2019 Drugstudy_ Grand Cp
6/16
NAME OF PATIENT: DRUGSTUDY DIAGNOSIS:
Name of Drug Date
Ordered
Classification Recommended
Dose & Frequency
Why given to
patient in relation tothe mechanism of
action
Contraindicat
ion
Side Effects/Toxic
effects/Drug-druginteraction
Stability of
the Drug
Nursing Consider
Generic (Brand)
CefipimeHydrochloride
(Axera)
Dose/Frequency
Prescribed
1g in 100cc D5Win soluset of 8hrs
infusion no ANST
November
17, 2012
Antibiotic
Cephalosporins(third
generation)
Adults:2-8g/day IM or IV
equally divideddoses every 6-8hr.
Do not exceed12g/day.
It is given to pt. to
treat infection.The pt. manifested
pneumonia.
Therapeutic action:Bactericidal:
Inhibits synthesis ofbacterial cell wall,
causing cell death.
Contraindicated with
allergy tocephalospori
ns andpenicillins.
CNS:Headache, dizziness,lethargy, paresthesias.GI:N & V, diarrhea, anorexia,abdominalpain,pseudomembraneous
colitis.GU: Nephrotoxicity
HEMATOLOGICBone marrow epression-decreased WBC count,
platelets and Hct.
DRUG-DRUGINTERACTION:
Increased nephrotoxicitywith aminoglycosides,monitor renal function test.Increased bleeding effectswith oral anticoagulants,reduced dosage may beneeded.Increased toxicity ifcombined with alcohol,
avoid this combinationduring and for 3 days aftercompleting therapy.
Storebetween 15-
30 degreeCelsius (59-
86 degreeFahrenheit)
avoidexcessive
humidity
Do not drink awhile taking t
and for 3 daysdrug has been
severe reactiooccur.
You may expethese side effe
stomach upseappetite, naus
diarrhea, head
dizziness. Report severediarrhea, diffi
breathing, unutiredness or fa
pain at injecti Have vitamin
available in ca
hypoprothromoccurs.
Culture infectand arrange fo
sensitivity tesgiving therapy
-
7/29/2019 Drugstudy_ Grand Cp
7/16
NAME OF PATIENT: DRUGSTUDY DIAGNOSIS:
Name of Drug DateOrdered
Classification Recommended Dose& Frequency
Why given to patientin relation to the
mechanism of action
Contraindication SideEffects/Toxic
effects/Drug-druginteraction
Stability ofthe Drug
Nursing Consider
Generic (Brand)
Clopidoreglbisulfate
Dose/FrequencyPrescribed
75mg/tab 1 tabOD
November26, 201
Antiplatelet
Adults:
300mg PO loadingdose, then 75mg/day
PO with aspirin,given at a dose from
75-325mg oncedaily.
Treatment to pt. at
risk for ischemicevents.
Therapeutic action:
Inhibits plateletaggregation byblocking ADP
receptors onplatelets, preventing
clamping ofplatelets.
Contraindicated
with allergy toclopidogrel,
activepathological
bleedeing such aspeptic ulcer or
intracranialhemorrhage,
lactation.
Use cautiouslywith bleedingdisorders, recent
surgery, hepaticimpairment.
CNS:
Headache,dizziness,
weakness, syncope,flushing.CV:Hypertension,edema.
DERMATOLOGIC:Rash, pruritus.
GI:Nausea. GI distress,constipation,diarrhea, GI bleed.
DRUG-DRUGINTERACTION:Increased risk of GIbleding withNSAID, monitor
patient carefully.Increased risk ofbleeding with
warfarin; monitorcarefully.
Store
between 15-30 degree
Celsius (59-86 degree
Fahrenheit)avoid
excessivehumidity
Provide frequentmeals if GI upset
not a s common Provide comfort
and arrange for aheadache occurs
Monitor patient fincreased bleedininvasive procedu
Take daily as premay be taken wit
report rash, chestfainting, severe habnormal bleedin
bruising.
You may experieside effects: dizz
lightheadedness,pass as you adjusdrug), headache
in a cool environrest; over the cou
preparations maynausa, gastric disfrequent small m
prolonged bleedidentist and healthprovider of this d
-
7/29/2019 Drugstudy_ Grand Cp
8/16
NAME OF PATIENT: DRUGSTUDY DIAGNOSIS:
Name of Drug DateOrdered
Classification Recommended Dose& Frequency
Why given to patientin relation to the
mechanism of action
Contraindication SideEffects/Toxic
effects/Drug-druginteraction
Stability ofthe Drug
Nursing Consider
Generic (Brand)
Furosemide( Lasix )
Dose/FrequencyPrescribed
20 mg IV now
November26, 2012
Loop diuretic
Adults:
4o mg IV over 1-2min. May be
increased to 80mg IVgiven over 1-2min if
responseunsatisfactory after
1hr.
It is given to patient
to treat acutepulmonary edema.
Therapeutic actions:
Inhibits reabsorptionof sodium andchloride from the
proximal and distaltubules and
ascending limb atthe loop of Henle,
leading to a sodium-rich diuretics.
Contraindicated
with allergy offurosemide,
sulfonamides;allergy to
tartazine ( in oralsolution); anuria;
severe renalfailure; hepatic
coma.
Use cautiouslywith SLE, gout,Diabetes mellitus.
CNS:
Dizziness, vertigo,
xanthopsia,
weakness, headache,
irreversible hearing
loss.
CV:
Orthostatic
hypotension, volume
depletion,
thrombophlebitis.
DERMATOLOGIC:
Rash, pruritus,urticaria, purpura,
dermatitis.
GI:
Nausea, anotexia,
vomiting, jaundice,
acute pancreatitis.
DRUG-DRUG
INTERACTION:
Increased risk of
cardiac arrhythmias
with catdiac
glycosides. increased
risk of ototoxicitywith aminoglycosides
antibiotics.
Store
between 15-30 degree
Celsius (59-86 degree
Fahrenheit)avoid
excessivehumidity
Administer wior ,milk to pre
upset. Reduce dosage
with otherantihypertensi
readjust dosag
gradually as B
responds. Give early in t
that increased will not disturb
Avoid IV use iuse as it is pos
Do not exposewhich may dis
tablet or oral sdo not use disc
drug or solutio Report loss or
more than 1.5kday, swelling i
ankles or finge
-
7/29/2019 Drugstudy_ Grand Cp
9/16
NAME OF PATIENT: DRUGSTUDY DIAGNOSIS:
Name of Drug DateOrdered
Classification Recommended Dose& Frequency
Why given topatient in relation to
the mechanism ofaction
Contraindication Side Effects/Toxiceffects/Drug-drug
interaction
Stability ofthe Drug
Nursing Conside
Generic (Brand)
Hydrocortisonesodium succinate
(solu-cortef)
Dose/FrequencyPrescribed
100mg every 8hrs
Novenber17, 2012
Corticosteroidhormones
100-500 mg initiallyand every 2, 4, or 6
hour based oncondition and
response.
It is given to pt. to
preventinflammation of the
lungs that will leadthe pt. in difficulty
of breathing.
Contraindicated
with allergy toany component of
the drug, fungalinfections,
amebiasis,hepatitis b,
vacinia, orvaricella,and
antibiotic
resistantinfections,immunosuppressi
on.
CNS:Vertigo, headache,
insomnia, psychosis.
CV:
Hypotension, shock,
hypertension and heart
failure secondary to
fluid retention.
EENT:
Cataracts, glaucoma.
GI:
Peptic or esophageal
ulcer, pancreatitis.MUSCULOSKELET
AL:
Muscle weakness,
osteoporosis,
spontaneous fracture.
DRUG-DRUG
INTERACTION:
Increased steroid
blood levels with
hormonal
contraceptives,
troleandomycin,
ketoconazole,
estrogen.
Decreased serum level
of salicylates.
Store
between 15-30 degree
Celsius (59-86 degree
Fahrenheit)avoid
excessivehumidity
Check label of hydrocortisoneroute that can ba particular prebecause IM andare not necessainterchangeabl
No part of hydacetate intrarecaerosol containbe inserted into
When corticostgiven chronicasmallest dose pthat will achievdesired effect.
At frequent intdose of medicashould be gradudecreased to desymptoms of dbe effectively cby the smaller drug.
-
7/29/2019 Drugstudy_ Grand Cp
10/16
NAME OF PATIENT: DRUGSTUDY DIAGNOSIS:
Name of Drug DateOrdered
Classification Recommended Dose& Frequency
Why given to patientin relation to the
mechanism of action
Contraindication SideEffects/Toxic
effects/Drug-druginteraction
Stability ofthe Drug
Nursing Consider
Generic (Brand)
Lactulose
Dose/Frequency
Prescribed
10cc every HS
Hold for BM 2xdose
November29,2012
Laxative
Adults:
15-30ml/day (10-20g/day) as a single
dose after breakfast(up to 60ml/day may
be required).
It is given to patient
for the treatment ofconstipation.
Therapeutic action:
The drug passesunchanged into the
colon where the
bacteria break itdown into organicacids that increase
the osmotic pressurein the colon and
slightly acidify thecolonic contents,
resulting in anincrease in stool
softening, laxativeaction.
Contraindicated
with allergy tolactulose, low
galactose diet.Use cautiously
with diabetes,pregnancy and
lactation.
GI:
Transientflatulence,
distention,intestinal cramps,
belching,diarrhea, nausea.
OTHER:Acid-base
imbalances,
electrolyteimbalance.
Store below
30 DegreeCelsius.
Avoidfreezing.
Report any pt. of GI distress. problem may sthe therapy conthe dose of memay need to be
The medicationcarbohydrate. Tobserve pt. for dry skin, compdry mouth and
thirst, a fruity obreath, abdomiand low BP. Thsymptoms ofhyperglycemiamore likely to oclients with dia
Keep th client cdry. Assess skicondition frequbecause skin brmay occur rapi
To minimize swdilute with watjuice or add to
-
7/29/2019 Drugstudy_ Grand Cp
11/16
NAME OF PATIENT: DRUGSTUDY DIAGNOSIS:
Name of Drug DateOrdered
Classification Recommended Dose& Frequency
Why given to patientin relation to the
mechanism of action
Contraindication SideEffects/Toxic
effects/Drug-druginteraction
Stability ofthe Drug
Nursing Consider
Generic (Brand)
Meropenenem(Merrem)
Dose/FrequencyPrescribed
1g IV every 8
hrs. ANST
November20, 2012
Antibiotic Adults:
Meningitis, intra-
abdominal
infections:
1g IV every hr.
Skin and skin
structure infection:500mg IV every 8hr.
Therapeutic action:
Bactericidal: Inhibitssynthesis of bacterialcell wall and causes
cell death insusceptible cells.
Contraindicated
with allergy tocephalosporins,
penicillins, beta-lactams, lctstion.
Use cautiously
with CNSdisorders,
seizures, renal or
hepaticimpairment.
CNS:
Headache,dizziness,
lethargy, seizures,insomnia.
GI:N & V, diarrhea,
anorexia,abdominal pain,
flatulence,
pseudomembraneous colitis, livertoxicity.
DRUG-DRUG
INTERACTION:Possible toxic
levels ifcombined with
probenecid; avoidthis combination.
Store
between 15-30 degree
Celsius (59-86 degree
Fahrenheit)avoid
excessivehumidity
This drug can given IV.
You may expethese side effe
stomach upsetappetite, nause
drug with food
diarrhea(stay n
bathroom),headizziness.
Report severe difficulty breat
unusual tirednat injection sit
Monitor forsuperinfection
arrange treatm
appropriate. Discontinue dr
sign of colitis
arrange for app
supportive trea
-
7/29/2019 Drugstudy_ Grand Cp
12/16
NAME OF PATIENT: DRUGSTUDY DIAGNOSIS:
Name of Drug DateOrdered
Classification Recommended Dose& Frequency
Why given to patientin relation to the
mechanism of action
Contraindication
Side Effects/Toxiceffects/Drug-drug
interaction
Stability ofthe Drug
Nursing Consid
Generic (Brand)
Omeprazole
(Omestop)
Dose/Frequency
Prescribed
40mg/tab
November
14, 2012
Proton pump
inhibitor20mg PO daily for
2-8wk. should not beused for
maintenancetherapy.
It is given to pt. to
prevent fromirritation of the inner
lining of thestomach.
Contraindicat
ed withhypersensitiv
ity toomeprazole
or itscomponents.
CNS:
Headache, dizziness,asthenia, vertigo,
insomnia, apathy, anxiety.DERMATOLOGIC:rash,
inflammation, urticaria,pruritus, alopecia, dry
skin.GI:
Iarrhea, abdominal pain,
constipation, dry mouth,tongue atrophy.RESPIRATORY:
URI symptoms, cough,epistaxis.
DRUG-DRUGINTERACTION:
Increased serum levelsand potential increase in
toxicity ofbenzodiazepines,
phenytoin, warfarin,; if
these combinations areused, monitor pt. closely.
Store
between15-30
degreeCelsius
(59-86degree
Fahrenheit)avoid
excessive
humidity
Administer bmeals. Cautiswallow caps
whole-not tochew, or crus
using oral suempty packe
cup containinwater. Stir an
to drink imm
fill cup with have pt. drinkwater. Do no
other diluent Administer a
with, if neede Review the l
effects assocdrug therapy
instruct clienpersistent sym
Report any curinary elimipain and discassociated w
-
7/29/2019 Drugstudy_ Grand Cp
13/16
NAME OF PATIENT: DRUGSTUDY DIAGNOSIS:
Name of Drug DateOrdered
Classification Recommended Dose& Frequency
Why given to patientin relation to the
mechanism of action
Contraindication SideEffects/Toxic
effects/Drug-druginteraction
Stability ofthe Drug
Nursing Consider
Generic (Brand)
Dose/Frequency
Prescribed
-
7/29/2019 Drugstudy_ Grand Cp
14/16
Name of Drug Date
Ordered
Classification Recommended Dose
& Frequency
Why given to patient
in relation to themechanism of action
Contraindication Side
Effects/Toxiceffects/Drug-drug
interaction
Stability of
the Drug
Nursing Consider
-
7/29/2019 Drugstudy_ Grand Cp
15/16
NAME OF PATIENT: DRUGSTUDY DIAGNOSIS:
Generic (Brand)
Dose/FrequencyPrescribed
Name of Drug Date
Ordered
Classification Recommended Dose
& Frequency
Why given to patient
in relation to themechanism of action
Contraindication Side
Effects/Toxiceffects/Drug-drug
interaction
Stability of
the Drug
Nursing Consider
-
7/29/2019 Drugstudy_ Grand Cp
16/16
NAME OF PATIENT: DRUGSTUDY DIAGNOSIS:
Generic (Brand)
Dose/FrequencyPrescribed